Summary
Masahiko Hara is an MD, PhD clinician-entrepreneur with 11 years of experience at the intersection of cardiovascular medicine, neurorehabilitation, and medical technology. As CEO and Founder of mediVR, Inc., he pioneered Somato-Cognitive Coordination Therapy (SCCT), a novel VR-based brain reprogramming treatment, and holds over 39 international patents supporting his platforms. A prolific researcher with 94 peer-reviewed publications and multiple top awards from AHA, ACC, JCC and METI (including a national Grand Prix), he blends rigorous clinical trial design and biostatistics with product-driven commercialization. He also serves as Visiting Professor at Shimane University and has repeatedly been recognized among the world’s most promising young cardiologists—evidence of rare dual strength in bedside care and scalable medical innovation. An unexpected thread in his profile is sustained success across academia, startup leadership, and IP strategy, highlighting his ability to translate complex cardiovascular science into impactful, market-ready therapies.
11 years of coding experience
1 year of employment as a software developer
Doctor of Medicine (MD), Medicine, Doctor of Medicine (MD), Medicine at Shimane Medical University
Doctor of Philosophy (PhD), Cardiovascular Medicine, Doctor of Philosophy (PhD), Cardiovascular Medicine at Osaka University Graduate School of Medicine
Japanese, English